Copyright
©The Author(s) 2024.
World J Cardiol. Aug 26, 2024; 16(8): 448-457
Published online Aug 26, 2024. doi: 10.4330/wjc.v16.i8.448
Published online Aug 26, 2024. doi: 10.4330/wjc.v16.i8.448
Figure 2 Mean change in systolic blood pressure concerning treatment group and its baseline level.
DPP-4i: Dipeptidyl peptidase-4 inhibitors; SGLT2i: Sodium-dependent glucose transporters inhibitors.
- Citation: Grubić Rotkvić P, Rotkvić L, Đuzel Čokljat A, Cigrovski Berković M. Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure. World J Cardiol 2024; 16(8): 448-457
- URL: https://www.wjgnet.com/1949-8462/full/v16/i8/448.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i8.448